Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: J Cyst Fibros. 2022 Mar 31;21(5):811–820. doi: 10.1016/j.jcf.2022.03.007

Table 2.

The seven genetic variants significantly associated with circulating CC16 levels§ among 289 EPIC participants after FDR adjustment and LD-based pruning.

Position rs ID Alt. Allele Ref. Allele MAF^ Gene Coef. (95% CI)* P FDR R-squared
62186542 rs3741240 A G 0.335 SCGB1A1 −0.634 (−0.778, −0.490) 6.2 × 10−18 4.3 × 10−16 0.190
62197427 rs2077224 A C 0.357 AHNAK 0.315 (0.158, 0.471) 8.3 × 10−5 0.002 0.048
62190700 rs2302364 C T 0.172 SCGB1A1 −0.411 (−0.616, −0.205) 8.9 × 10−5 0.002 0.046
34937697 rs2016814 C T 0.203 PDHX, APIP −0.281 (−0.458, −0.104) 0.002 0.022 0.028
34909926 rs1571133 G T 0.323 APIP −0.234 (−0.394, −0.074) 0.004 0.031 0.023
34842506 rs568529 A C 0.295 -- −0.233 (−0.405, −0.060) 0.008 0.038 0.019
34780278 rs906902 A G 0.393 -- −0.207 (−0.363, −0.051) 0.009 0.039 0.016
§

Standardized levels of log-transformed CC16 were used in analyses

^

MAF: minor allele frequency

*

The coefficient indicates the change in SDs of CC16 levels associated with one-allele change of the specific genetic variant from additive models.